NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/26/2025
Back to search
Official data from USPTO
INVICRO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
63
Latest update
08/26/2025
Trademark type
Combined
Nice classes
9, 41, 42, 44
Filing date
09/08/2021
Registration date
08/26/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/26/2025
Last transaction
08/26/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2008-08-00
First use in commerce
2008-08-00
Drawing code
3
Owner type
16
Owner location
Needham, MA, US
Examiner
JOHNSON, DANYTHE ELIZABETH HA
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of an image of an overhead shot of a magnifying glass with a loupe in the circle with the word "INVICRO" to the right of the image.
Holders and representatives
Holders
Invicro, LLC
Representatives
Devon E. White Wyrick Robbins Yates & Ponton LLP
Technical classification
Nice Classes
Class 9Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable computer software for processingvisualizingstoring and analyzing pre-clinical and clinical radiology and pathology image data in the fields of drug development and disease research; downloadable computer software for image data management purposespre-clinical and clinical image database management and research subject records management; downloadable computer software for processing multi-modal imaging data; downloadable computer software for the processingstorage and analysis of multi-modal imaging data for quantitation and evaluation of biomarkers and drug candidates; downloadable software for the assessment of tumors for research through use of biomarkers
Class 41
Educational servicesdevelopingarranging and conducting educational programspanel discussions and non-downloadable webinars in the fields of pharmaceuticalsbiotechnologypre-clinical and clinical trialsmedical research; educational servicesproviding non-downloadable publications in the nature of blogposts and magazinesnon-downloadable literature in the nature of periodicals and books in the fields of pharmaceuticalsbiotechnologypre-clinical and clinical trialsmedical research
Class 42
Medical and scientific researchconducting clinical trial services for others and pre-clinical trial services for others in the nature of testing of pharmaceuticals; pharmaceutical research and development services; testing of pharmaceutical pharmacodynamicspharmacokinetics and efficacy using a variety of imaging modalities and imaging analysis platforms; imaging services and pathology in support of pharmaceutical research and developmentresearch of disease and non-medical ultrasound imaging servicesall for the research and development of pharmaceuticals; drug discovery services; conducting early evaluations in the field of new drugs; scientific investigations for medical research purposes; medical and scientific research laboratory services; medical and scientific researchproviding analysis of imaging data obtained from pre-clinical and clinical trial studies; medical and scientific research in the fields of medical radiology imagingpathology and digital pathology; providing medical and scientific research information in the fields of pharmaceuticals and biotechnology; research and development in the fields of medical imagingpharmaceuticals and biotechnology; designdevelopmentmaintenance and updating of computer software for image processingstorage and analysis in the fields of pharmaceuticals and biotechnology; electronic storage of medical images; processing of medical imagesdigital image interpretation for scientific research and medical research purposeslabelingcorrectionrestoration and enhancement; pathology services in support of drug developmentmedical research regarding diseases for the purpose of developing drugs; hosting of a medical imaging analysis and visualization platform in the nature of a website through a global computer network; hosting of digital content on the Internethosting of a database of medical images; software as a service (SAAS) featuring computer software platforms for image processingstorage and analysis in the fields of pharmaceuticals and biotechnology; conducting clinical trials for others at all stages and in various indicationsparticularly in oncologyneurology and systemic diseases; imaging contract research organization services and technology solutionsnon-medical ultrasound imaging services for medical and scientific research purposes and technology solutionsreviewing of radiology images throughout the clinical trial process and blinded independent central review of radiology images in the medical research and clinical trial setting for medical research and scientific research purposes; scientific research servicesintegration of imaging results with clinical outcome datawith application of machine learning and artificial intelligence applications; development and evaluation in the nature of testing of imaging biomarkers for clinical trial purposes; software consulting services in the field of drug discovery; cloud computing featuring software for use in database management for use in pharmaceutical drug research in the field of drug discovery; radiochemistry services in the nature of radiolabeling for scientific research and medical research purposes and radiochemical analysis; researchdevelopment and testing services relating to radiopharmaceuticals; radiolabeling scientific researchlabeling of both small molecules and biologics; providing non-downloadable web-based computer software for database management in the fields of medical imagingpharmaceutical and biotechnology research; medical imaging and radiology services related to drug developmentmedical imaging and radiology services of clinical trial patients for research purposes; medical and scientific research services in the fields of magnetic resonance and molecular imaging; medical research servicesin particular services relating to the development of radiotherapeutics and drug candidates for neurodegenerative diseases and precision oncology; image analysis and radiologyanalysis of images from all radiological modalitiessuch as but not limited to CTMRI and PET scansto provide quantitative evaluation of drug candidates medical radiologymolecular imagingimaging utilizing radiopharmaceuticals for medical research and pharmaceutical development purposes; pathology servicestesting for research purposes in the fields of pharmaceuticals and biotechnology; pathology services for preclinical biomarker discovery research and clinical trials
Class 44
Medical imaging services; medical imaging and radiology services related to drug developmentmedical imaging and radiology services of clinical trial patients for medical purposes; image analysis and radiologyanalysis of images from all radiological modalitiessuch as but not limited to CTMRI and PET scans to provide quantitative evaluation of drug candidates medical radiologymolecular imagingimaging utilizing radiopharmaceuticals for the diagnosis and medical treatment of trial candidates; radiomicsmedical radiology services; medical imaging servicesmedical imaging and extraction of imaging biomarkers; analysis of medical imagesmedical analysis of medical images for diagnosis and treatment of persons in clinical trials
Publications
History of USPTO decisions and trademark events.
63 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/26/2025
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
08/01/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/02/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/02/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/01/2025
IUCN
NOTICE OF ALLOWANCE CANCELLED
06/20/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/03/2025
GNRT
NON-FINAL ACTION E-MAILED
04/03/2025
CNRT
SU - NON-FINAL ACTION - WRITTEN
04/03/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/03/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/02/2025
EX3G
SOU EXTENSION 3 GRANTED
03/02/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/02/2025
IUAF
USE AMENDMENT FILED
12/19/2024
EXT3
SOU EXTENSION 3 FILED
12/19/2024
EISU
TEAS STATEMENT OF USE RECEIVED
12/19/2024
EEXT
SOU TEAS EXTENSION RECEIVED
12/19/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/20/2024
EX2G
SOU EXTENSION 2 GRANTED
06/20/2024
EXT2
SOU EXTENSION 2 FILED
06/20/2024
EEXT
SOU TEAS EXTENSION RECEIVED
06/20/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/13/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/13/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/13/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/13/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/13/2024
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
05/22/2024
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
05/22/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/15/2023
EX1G
SOU EXTENSION 1 GRANTED
12/13/2023
EXT1
SOU EXTENSION 1 FILED
12/13/2023
EEXT
SOU TEAS EXTENSION RECEIVED
12/13/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/20/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/25/2023
PUBO
PUBLISHED FOR OPPOSITION
04/25/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/05/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/17/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
03/17/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/17/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
03/17/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/17/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/13/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/13/2023
ALIE
ASSIGNED TO LIE
03/11/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/11/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/11/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/11/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/11/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/11/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/29/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/06/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/06/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/06/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/06/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/06/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/29/2022
GNRT
NON-FINAL ACTION E-MAILED
06/29/2022
CNRT
NON-FINAL ACTION WRITTEN
06/29/2022
DOCK
ASSIGNED TO EXAMINER
06/13/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/19/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/18/2021
NWAP
NEW APPLICATION ENTERED
09/11/2021
Continuous trademark protection
Get notified about every new filing that threatens INVICRO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.